Sigumir is a cytomax containing peptide bioregulators isolated from bone and cartilage tissue of young animals. The supplement aims to restore the function of the musculoskeletal system.
Peptides on the base of Sigumir selectively impact human bone and connective tissue, improving its metabolism, nutrition, and activating regeneration processes. In this way, the natural process of human musculoskeletal system healing begins.
The supplement is used for diseases of the bones, joints, and vertebrae that developed due to improper diet, aging, injuries, and metabolic disorders. Sigumir is effective as for prophylactic, as in complex therapy.
- prophylactic and treatment dysfunction of the musculoskeletal system, including age-related
- physical activities, including extreme activities (professional training, hard work)
- improving performance in sports and preventing injury
- long periods spent on the legs as well as in high heels
- inflammatory joint disease (arthritis)
- degenerative-dystrophic changes in the joints (arthrosis)
- rheumatological diseases
- spine diseases (osteochondrosis, etc.)
- prophylactic and treatment of osteoporosis
Individual intolerance to the components, pregnancy, breastfeeding. Therefore, it is recommended to consult your doctor before taking the supplement.
Instructions for using Sigumir
Adults should take 1-2 capsules of Sigumir 1-2 daily during meals.
The duration f the course is one month.
In severe forms of the disease or the presence of accompanying pathologies, the course can be prolonged and supplemented with peptide bioregulators of other organs and therapeutic and prophylactic supplements.
During chronic conditions, it is recommended to undergo the course 2-3 times per year to extend remission. Patients with chronic diseases should consult their healthcare provider before taking the supplement.
Composition of Sigumir
- Peptide complex A-4 (cartilage peptides)
- Additional components: microcrystalline cellulose, gelatin (encapsulating agent), lactose (water-retaining filler).
The effects of Sigumir's action
Khavinson's peptides in the Sigumir supplement activate the natural regeneration processes of cartilaginous and bone tissues. The addition of this supplement to the primary treatment of the bones, joints, and vertebrae disease significantly increases the effectiveness of treatment. With the use of this supplement, the patient experiences pain reduction, increased joint mobility, increased bone density, and an improvement in quality of life.
As a mono-medication, Sigumir is prescribed to prevent diseases of the musculoskeletal system. It is recommended for elderly and old people, women in the period of menopause. Moreover, Sigumir is beneficial for people over 30-35 years old that are at higher risk of joints, bones, and vertebrae diseases. It includes high physical activity, lack of nutrition (calcium, phosphorus, vitamin D3), impaired absorption of nutrients, hormonal disorders, taking certain medications (corticosteroids, NSAIDs).
Sigumir has shown a high degree of safety and no addictive effect as all bioregulators.
Sigumir must be taken according to the instructions. It is recommended to consult your doctor before using the supplement.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
How you can buy Sigumir
At our online store, you can order the delivery of Sigumir anywhere in the USA and choose a convenient payment method (payment by card, PayPal, and much more).